|
시장보고서
상품코드
2048814
모유 올리고당(HMO) 시장 규모, 점유율 및 성장 분석 : 유형별, 제품 유형별, 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Human Milk Oligosaccharides (HMO) Market Size, Share, and Growth Analysis, By Type (2´FL, 3´FL), By Product (Fucosyllactose, Lnt & LNnt), By Application, By Distribution channel, By Region - Industry Forecast 2026-2033 |
||||||
모유 올리고당(HMO) 시장 규모는 2024년 2억 2,964만 달러, 2025년 2억 5,330만 달러에서 2033년까지 5억 5,493만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 10.3%를 보일 전망입니다.
모유 올리고당(HMO) 시장은 영유아의 건강과 영양에 중요한 역할을 하는 것으로 인식되고 있습니다. 모유에 자연적으로 함유되어 있는 복합 탄수화물은 유아의 면역 기능 향상, 위장 건강, 인지 발달 촉진 등 다양한 건강상의 이점을 제공합니다. 이러한 장점에 대한 인식이 높아짐에 따라 HMO에 대한 수요는 영유아 영양식품을 넘어 의약품, 기능성 식품, 프리바이오틱스 보충제 등 다양한 분야로 확대되고 있습니다. 소비자들은 모유의 건강 효과를 모방한 천연 유래 솔루션을 점점 더 많이 찾고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 그러나 HMO 생산의 복잡성, 규제 장벽, 지적재산권 문제 등의 문제가 시장 역학에 영향을 미치고 있습니다. 현재 진행 중인 연구를 통해 혁신적인 HMO 제제가 개발되어 인간의 생애주기 전반에 걸쳐 건강 상태를 개선할 수 있는 가능성이 확대될 것으로 기대됩니다.
모유 올리고당(HMO) 시장 성장 요인
모유 올리고당(HMO)과 관련된 건강상의 이점이 점점 더 많이 알려지면서 시장 성장의 중요한 촉매제가 되고 있습니다. HMO가 유아의 면역 기능 향상, 인지 발달 촉진, 장내 환경 유지에 중요한 역할을 한다는 소비자의 인식이 높아지면서 HMO가 강화된 제품에 대한 수요가 크게 증가하고 있습니다. 이러한 관심은 유아의 건강에 국한되지 않고, 성인층도 HMO의 잠재적 이점에 주목하면서 시장을 더욱 견인하고 있습니다. 인지도가 계속 확산됨에 따라 HMO가 함유된 제품의 매력은 다양한 소비자층에서 더욱 확대될 것으로 예측됩니다.
모유 올리고당(HMO) 시장 성장 억제요인
모유 올리고당(HMO) 시장은 합성과 관련된 복잡성으로 인해 심각한 문제에 직면해 있습니다. HMO 생산은 매우 복잡한 특성으로 인해 확장성과 비용 효율성을 실현하기가 어렵습니다. 천연 모유에 함유된 다양한 HMO 구조를 재현하는 데 필요한 방법은 복잡하고 비용이 많이 들기 때문입니다. 결과적으로 이러한 요인들은 시장의 전반적인 성장 잠재력을 저해하고, 더 많은 소비자층에게 HMO의 보급을 제한할 수 있으며, 결과적으로 이러한 유익한 화합물을 활용한 제품 개발 전체에 영향을 미칠 수 있습니다.
휴먼 밀크 올리고당(HMO) 시장 동향
모유 올리고당(HMO) 시장은 그 용도가 영유아 영양식품을 넘어 더 넓은 건강 및 웰빙 분야로 확대되면서 눈에 띄는 변화를 겪고 있습니다. 연구자들이 HMO의 잠재적 이점에 대해 더 깊이 파고들면서 기능성 식품, 영양 보충제, 그리고 다양한 연령대의 다양한 건강 상태에 대한 치료적 개입에서 HMO의 효능이 밝혀지고 있습니다. 이러한 추세는 장 건강, 면역력 및 전반적인 웰빙에 대한 소비자의 인식이 높아지면서 HMO가 풍부한 제품에 대한 수요가 증가하고 있습니다. 그 결과, 시장은 빠르게 진화하고 있으며, 다양한 계층의 니즈를 충족시키는 혁신적인 제형과 제품이 등장하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 모유 올리고당(HMO) 시장 규모 : 유형별
세계의 모유 올리고당(HMO) 시장 규모 : 제품별
세계의 모유 올리고당(HMO) 시장 규모 : 용도별
세계의 모유 올리고당(HMO) 시장 규모 : 유통 채널별
세계의 모유 올리고당(HMO) 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSHHuman Milk Oligosaccharides (HMO) Market size was valued at USD 229.64 Million in 2024 and is poised to grow from USD 253.3 Million in 2025 to USD 554.93 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).
The Human Milk Oligosaccharides (HMO) market is gaining recognition for its crucial role in infant wellness and nutrition. Naturally occurring in human breast milk, these complex carbohydrates offer numerous health benefits, including enhanced immune function, gastrointestinal health, and cognitive development in infants. Increased awareness of these advantages drives demand for HMOs beyond baby nutrition, with applications emerging in pharmaceuticals, functional foods, and prebiotic supplements. Consumers are increasingly seeking natural solutions that mimic the health properties of breast milk, further fueling growth. However, challenges such as the complexity of HMO production, regulatory hurdles, and intellectual property issues impact market dynamics. Ongoing research is expected to unlock innovative HMO formulations, expanding their potential to improve health outcomes throughout the human lifecycle.
Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (HMO) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Human Milk Oligosaccharides (HMO) Market Segments Analysis
Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Human Milk Oligosaccharides (HMO) Market
The increasing recognition of the health benefits associated with human milk oligosaccharides (HMOs) serves as a significant catalyst for market growth. As consumers become more informed about the vital role HMOs play in enhancing immune function, fostering cognitive development, and supporting gut health in infants, there has been a notable rise in demand for HMO-enriched products. This growing interest is not limited to infant health; adults are also exploring the potential advantages of HMOs, further driving the market. As awareness continues to spread, the appeal for HMO-infused offerings is likely to expand within various consumer segments.
Restraints in the Human Milk Oligosaccharides (HMO) Market
The Human Milk Oligosaccharides (HMO) market faces significant challenges due to the complexities involved in their synthesis. The intricate nature of HMO production poses difficulties in achieving scalability and cost-effectiveness, as the methods required to replicate the diverse array of HMO structures found in natural breast milk are both complicated and expensive. As a result, these factors hinder the overall growth potential of the market and may limit the accessibility of HMOs to a broader consumer base, thereby impacting the overall development of products that utilize these beneficial compounds.
Market Trends of the Human Milk Oligosaccharides (HMO) Market
The Human Milk Oligosaccharides (HMO) market is witnessing a notable shift as applications extend beyond infant nutrition, tapping into a broader health and wellness agenda. As researchers delve deeper into the potential benefits of HMOs, they are uncovering their efficacy in functional foods, dietary supplements, and even therapeutic interventions for various health conditions across different age groups. This trend is driven by increasing consumer awareness of gut health, immunity, and overall well-being, leading to greater demand for HMO-enriched products. Consequently, the market is evolving rapidly, with innovative formulations and products catering to diverse demographic needs.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2026-2033)
- Market Overview
- 2'FL
- 3'FL
- 3'SL
- 6'SL
Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2026-2033)
- Market Overview
- Fucosyllactose
- Lnt & LNnt
- Sialyllactose
Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2026-2033)
- Market Overview
- Infant formula
- Functional food & beverages
- Food supplements
- Health ingredients for human and animal
- Other
Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2026-2033)
- Market Overview
- Hypermarkets and supermarkets
- Drug store or pharmacy
- Mass merchandiser
- Departmental stores
- Mono-brand stores
- Specialty stores
- Online sales channel
Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2026-2033)
- North America (Type, Product, Application, Distribution channel)
- US
- Canada
- Europe (Type, Product, Application, Distribution channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Product, Application, Distribution channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Product, Application, Distribution channel)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Product, Application, Distribution channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- DSM (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DuPont (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nestle (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inbiose NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gnubiotics Sciences S.A (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Royal FrieslandCampina N.V (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elicityl S.A (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dextra Laboratories (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glycom A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glycosyn (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medolac Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neolacta Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jennewein Biotechnologie GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Specialty Ingredients (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZuChem Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
